ML24106A121
| ML24106A121 | |
| Person / Time | |
|---|---|
| Issue date: | 04/15/2024 |
| From: | Carrie Safford NRC/SECY |
| To: | Raymond Furstenau NRC/EDO |
| References | |
| M240409B SRM-M240409B | |
| Download: ML24106A121 (1) | |
Text
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001
April 15, 202 4
IN RESPONSE, PLEASE REFER TO: M240409B
MEMORANDUM TO: Raymond V. Furstenau Acting Executive Director for Operations
FROM: Carrie M. Safford, Secretary
SUBJECT:
STAFF REQUIREMENTS - MEETING WITH THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES
On April 9, 202 4, the Commission was briefed on a variety of medical -related topics of regulatory interest by the following members of the Advisory Committee on the Medical Uses of Isotopes (ACMUI): Dr. Hossein Jadvar, ACMUI Chair and Nuclear Medicine Physician; Dr.
Richard Harvey, Radiation Safety Officer Representative; Megan Shober, Agreement State Representative; and Josh Mailman, Patients Rights Advocate. The topics discussed included an overview of ACMUI activities, ACMUIs review and analysis of reported medical events from fiscal years 2021-2023, ACMUI comments on revisions to Regulatory Guide (RG) 8.39, Release of Patients Administered Radioactive Material, and p atients rights advocates perspectives on RG 8.39 and reporting of n uclear medicine injection extravasations.
The meeting, which was held in the Commissioners Hearing Room, One White Flint North, Rockville, Maryland at 10 :00 a.m. Eastern Time, was open to members of the public attending in person and via webcast.
The Commission identified no requirements for staff action.
cc: Chair Hanson Commissioner Wright Commissioner Caputo Commissioner Crowell OGC CFO OCA OIG OPA ODs, RAs, ACRS, ASLBP PDR